肺移植后限制性移植物综合征的异常与异位细胞群
该研究对15例再次移植的RAS患者肺组织及9例健康对照肺组织进行单核RNA测序,发现RAS肺内存在异常的基底样细胞、异位的COL15A1+支气管周围血管内皮细胞及CTHRC1+纤维化成纤维细胞,这些细胞共同定位于肺泡纤维弹性组织增生的纤维化微环境,并揭示整合素αvβ6等潜在治疗靶点。
要点
- RAS肺组织中出现异常的基底样细胞、异位COL15A1+ pVECs和CTHRC1+纤维化成纤维细胞。
- 这些细胞在纤维化边缘形成肺泡纤维弹性组织增生的纤维化微环境。
- 微CT显示肺循环向体循环灌注转变,由COL15A1+ pVECs介导。
核心结论
- RAS与IPF存在多层面差异,但共享由异常基底样细胞、异位COL15A1+ pVECs和CTHRC1+纤维化成纤维细胞组成的纤维化微环境通用原则,提示潜在治疗手段可在进行性纤维化肺病间基于细胞发病机制灵活转化。
研究设计与样本
- 对15例再次移植的RAS患者外周肺组织及9例健康对照肺组织进行单核RNA测序,并用免疫荧光、RNA原位杂交、Elastica van Gieson免疫组化、定量组织学和微CT验证。
主要发现
- RAS肺中鉴定出先前未描述的异常基底样细胞、异位COL15A1+支气管周围血管内皮细胞和CTHRC1+纤维化成纤维细胞。
- 异常基底样细胞主要位于纤维化边缘,与CTHRC1+纤维化成纤维细胞及异位COL15A1+ pVECs相邻,共同构成肺泡纤维弹性组织增生的纤维化微环境。
- AFE区域中PRX+肺泡微血管部分丢失。
- 微CT显示由COL15A1+ pVECs介导的肺循环向体循环灌注转变。
关键数值与推荐
- RAS肺中异常基底样细胞主要定位于纤维化边缘。
- AFE区域中PRX+肺泡微血管部分丢失。
- 潜在治疗靶点包括整合素αvβ6(转化生长因子-β激活剂)。
临床怎么用
- 识别RAS纤维化微环境的细胞组成有助于理解发病机制。
- 整合素αvβ6等靶点提示RAS潜在治疗方向。
- RAS与IPF共享纤维化微环境原则,支持治疗思路跨病种转化。
局限性
- 样本量有限(RAS 15例,对照9例),需更大队列验证。
- 单核RNA测序及组织学发现需功能实验进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RATIONALE: Restrictive allograft syndrome (RAS) is a major cause of mortality following lung transplantation due to progressive fibrosis of the lung allograft, with no therapeutic options. Knowledge of the cellular and molecular mechanisms driving fibrosis in RAS remains limited. OBJECTIVE: To characterise the cellular and molecular changes in human RAS lungs through single-nucleus transcriptomic profiling. METHODS: Single-nucleus RNA-sequencing (snRNA-seq) was performed in peripheral lung tissues from 15 RAS patients undergoing lung re-transplantation, and from nine healthy control lungs. Findings were validated and extended using histological techniques including immunofluorescence, RNA in situ hybridisation, Elastica van Gieson immunohistochemistry, quantitative histological analyses, and micro-computed tomography (CT) scans. MEASUREMENTS AND MAIN RESULTS: snRNA-seq analysis of RAS lungs revealed previously undescribed aberrant basaloid cells, ectopic COL15A1+ peribronchial vascular endothelial cells (pVECs), and CTHRC1+ fibrotic fibroblasts. Histological stains disclosed distinctive distribution patterns: aberrant basaloid cells, primarily localised at the fibrotic edge, together with juxtaposed CTHRC1+ fibrotic fibroblasts and ectopic COL15A1+ pVECs form the fibrotic niche of alveolar fibroelastosis (AFE). PRX+ alveolar microvasculature is partially lost in AFE areas. Micro-CT scans revealed changes from pulmonary to systemic perfusion, facilitated by COL15A1+ pVECs. Lastly, our data reveal potential therapeutic targets in RAS, including integrin αvβ6, activator of transforming growth factor-β. CONCLUSION: Considering the multifaceted differences of RAS and idiopathic pulmonary fibrosis, we revealed a surprising general principle of an entity-spanning composition of the fibrotic niche by aberrant basaloid cells localised at the fibrotic edge, ectopic COL15A1+ pVECs and CTHRC1+ fibrotic fibroblasts. This suggests a flexible, but cellular pathogenesis-guided, transferability of potential therapeutic approaches between progressive fibrotic lung diseases.
引用
- Leiber LM, Christian L, Neubert L, et al. Aberrant and ectopic cell populations in restrictive allograft syndrome after lung transplantation. Eur Respir J. 2026. PMID: 42425730. doi:10.1183/13993003.00537-2025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。